2026 ICD-10-CM Diagnosis Code M34.9Systemic sclerosis, unspecified

ICD-10-CM Codes›M00–M99›M30-M36›M34

ICD-10-CM M34.9
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

M34.9 is a billable ICD-10-CM diagnosis code for systemic sclerosis, unspecified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 545 through 547. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Systemic lupus erythematosus and connective tissue disorders.

For Medicare Advantage risk adjustment, M34.9 maps to CMS-HCC Category 93 (Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders) under the V28 model, adding a risk factor of about 0.617 for a community, non-dual, aged beneficiary in payment year 2026.

Code Identity

ICD-10-CM Code
M34.9
Billable Status
Yes — Valid for Submission
Code Describes
Systemic sclerosis, unspecified
Short Description
Systemic sclerosis, unspecified
Same as the full description in the CMS dataset.
Parent Code
Systemic sclerosis [scleroderma]

Code Classification

ChapterM00–M99Diseases of the musculoskeletal system and connective tissue
SectionM30-M36Systemic connective tissue disorders
CategoryM34Systemic sclerosis [scleroderma]
This CodeM34.9Systemic sclerosis, unspecified

Medicare Risk Adjustment (HCC)Billing

M34.9 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2026.

CMS-HCC V28 Category (Payment Model)
HCC 93— Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders
Payment HCC · PY 2026 one of 508 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.617
community, non-dual, aged · ranges 0.288–0.617 across segments
Hierarchy
Supersedes HCC 94
less severe related categories are not paid alongside HCC 93
Prior Model (CMS-HCC V24)
HCC 40
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 40 · ESRD (V21): HCC 40 · ESRD (V24): HCC 40
ESRD V21 weights: 0.072 dialysis, 0.274–0.398 functioning graft · ESRD V24 weights: 0.058 dialysis, 0.284–0.414 functioning graft
Part D (RxHCC)
RxHCC 82 — Systemic Sclerosis
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2026 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Autoimmune cholangitis
  • Autoimmune hepatitis
  • Autoimmune liver disease
  • Biliary cirrhosis
  • Cardiomyopathy due to connective tissue disease
  • Cholangiohepatitis
  • Cutaneous complication of systemic sclerosis
  • Dilated cardiomyopathy due to scleroderma
  • Dilated cardiomyopathy due to systemic sclerosis
  • Fibrosis of bile duct
  • Gingival disease due to systemic sclerosis
  • Glomerulonephritis co-occurrent and due to scleroderma
  • Hypermelanosis due to connective tissue disorder
  • Hypothyroidism due to scleroderma
  • Hypothyroidism due to systemic sclerosis
  • Limited systemic sclerosis
  • Necrotizing vasculitis secondary to connective tissue disease
  • Occupational scleroderma
  • Pediatric onset systemic sclerosis
  • Pericarditis secondary to scleroderma
  • Poikiloderma due to scleroderma
  • Post-infectious scleredema
  • Primary biliary cholangitis
  • Progressive systemic sclerosis
  • Renal involvement in scleroderma
  • Reynolds syndrome
  • Scleredema
  • Sclerema
  • Scleroderma
  • Scleroderma-associated calcinosis
  • Scleroderma-associated hypermelanosis
  • Scleroderma-associated nail dystrophy
  • Scleroderma-associated nailfold telangiectasia
  • Scleroderma-associated necrotizing vasculitis
  • Scleroderma-associated telangiectasia
  • Systemic sclerosis
  • Systemic sclerosis with limited cutaneous involvement
  • Systemic sclerosis, diffuse
  • Telangiectasia of nailfolds
  • Thickening of skin

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MUS024
Systemic lupus erythematosus and connective tissue disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Scleroderma

Scleroderma means "hard skin." It's the name of an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. This inflammation causes you to have areas of tight, hard skin. Scleroderma may affect just one area of your body, or it can affect many systems in your body.

The full article covers:

  • What is scleroderma?
  • What are the types of scleroderma?
  • What causes scleroderma?
  • Who is more likely to develop scleroderma?
  • What are the symptoms of scleroderma?
  • How is scleroderma diagnosed?
  • What are the treatments for scleroderma?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert M34.9 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
710.1 Systemic sclerosis
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About M34.9Overview

What is the ICD-10 code for systemic sclerosis, unspecified?

The ICD-10-CM code for systemic sclerosis, unspecified is M34.9 (sometimes written as M349). It is billable on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Is M34.9 (Systemic sclerosis [scleroderma]) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report systemic sclerosis, unspecified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does M34.9 group to?

When systemic sclerosis, unspecified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 545, 546, 547, with relative weights from 0.8362 to 2.4817 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of M34.9?

Under the General Equivalence Mappings, systemic sclerosis, unspecified converts to ICD-9-CM 710.1 (systemic sclerosis). The mapping is approximate, so confirm the match fits the documentation.

What HCC is M34.9?

M34.9 (systemic sclerosis, unspecified) maps to CMS-HCC Category 93 (Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders), commonly written as HCC 93, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2026. It mapped to HCC 40 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 82.

Does M34.9 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, M34.9 adds a risk adjustment factor of about 0.617 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.288 to 0.617 depending on the payment segment). HCC 93 sits at the top of its hierarchy, so no other condition category supersedes it. See the full factor table on the HCC 93 category page.